2755-9734

BMJ Mental Health

BMJ

View prefix report (10.1136)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 18 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact18 DOIs
2

Deposit reference lists for 4 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact4 DOIs
3

Attach ORCID iDs across 4 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 357 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Explaining paranoia: cognitive and social processes in the o… (10.1136/bmjment-2023-300880)
ORCID
40.32 40
2 Is placebo response in antidepressant trials rising or not?… (10.1136/eb-2017-102827)
License
36.18 27
3 Blinding successfulness in antipsychotic trials of acute tre… (10.1136/bmjment-2023-300654)
Abstract
26.98 11
4 Exploring the minimal important difference in the treatment… (10.1136/bmjment-2024-300999)
Abstract
19.45 5
5 Population health surveys and screening tools for depressive… (10.1136/bmjment-2023-300757)
Abstract
17.47 4
6 Understanding and responding to the drivers of inequalities… (10.1136/bmjment-2023-300921)
Abstract
17.47 4
7 Association between severe childhood infections and subseque… (10.1136/bmjment-2024-301203)
Abstract
15.05 3
8 What I stand for as <i>BMJ Mental Health</i> editor (10.1136/bmjment-2023-300664)
Abstract
7.53 1
9 Genetic liability to bipolar disorder and onset of postpartu… (10.1136/bmjment-2023-300835)
Abstract
7.53 1
10 Correspondence on population health surveys and screening to… (10.1136/bmjment-2023-300838)
Abstract
7.53 1
11 Circadian rhythms and mental health (10.1136/bmjment-2025-301818)
Abstract
7.53 1
12 <i>Correction</i> : Introducing artifici… (10.1136/bmjment-2019-300136corr1)
Abstract References ORCID License
0.00 0
13 Associations between antipsychotics and the risk of incident… (10.1136/bmjment-2022-300501)
0.00 15
14 metaumbrella: the first comprehensive suite to perform data… (10.1136/bmjment-2022-300534)
0.00 77
15 Comparison of antipsychotic dose equivalents for acute bipol… (10.1136/bmjment-2022-300546)
0.00 10
16 Examining the Lancet Commission risk factors for dementia us… (10.1136/bmjment-2022-300555)
0.00 24
17 Symptom-specific effects of counselling for depression compa… (10.1136/bmjment-2022-300621)
0.00 6
18 Exploring the efficacy of psychotherapies for depression: a… (10.1136/bmjment-2022-300626)
0.00 20
19 Placebo response in trials with patients with anxiety, obses… (10.1136/bmjment-2022-300630)
0.00 15
20 Assessing violence risk in first-episode psychosis: external… (10.1136/bmjment-2022-300634)
0.00 11
21 Peer-provided psychological intervention for Syrian refugees… (10.1136/bmjment-2022-300637)
0.00 59
22 Decoding fMRI alcohol cue reactivity and its association wit… (10.1136/bmjment-2022-300639)
0.00 3
23 Understanding the causal relationships of attention-deficit/… (10.1136/bmjment-2022-300642)
0.00 10
24 Police-led real-time surveillance system for suspected suici… (10.1136/bmjment-2022-300643)
0.00 8
25 Evaluation of telepsychiatry during the COVID-19 pandemic ac… (10.1136/bmjment-2022-300646)
0.00 10
26 Racialised staff–patient relationships in inpatient mental h… (10.1136/bmjment-2023-300661)
0.00 8
27 Insulin resistance, age and depression’s impact on cognition… (10.1136/bmjment-2023-300665)
0.00 5
28 Digital mental health: challenges and next steps (10.1136/bmjment-2023-300670)
0.00 202
29 Self-Help Plus for refugees and asylum seekers: an individua… (10.1136/bmjment-2023-300672)
0.00 27
30 Risk of death by suicide following self-harm presentations t… (10.1136/bmjment-2023-300673)
0.00 26
31 Prevalence estimates of major depressive disorder in 27 Euro… (10.1136/bmjment-2023-300675)
0.00 20
32 Crossroads of methodological choices in research synthesis:… (10.1136/bmjment-2023-300677)
0.00 1
33 Tool to assess risk of bias in studies estimating the preval… (10.1136/bmjment-2023-300694)
0.00 22
34 Effectiveness of a mental health stepped-care programme for… (10.1136/bmjment-2023-300697)
0.00 38
35 Cause-specific excess mortality after first diagnosis of bip… (10.1136/bmjment-2023-300700)
0.00 19
36 Predicting outcomes at the individual patient level: what is… (10.1136/bmjment-2023-300701)
0.00 5
37 Depressive symptom networks in the UK general adolescent pop… (10.1136/bmjment-2023-300707)
0.00 6
38 Improving mental healthcare access and experience for people… (10.1136/bmjment-2023-300709)
0.00 6
39 Predictors of positive patient-reported outcomes from ‘Early… (10.1136/bmjment-2023-300716)
0.00 7
40 Increasing the value of digital phenotyping through reducing… (10.1136/bmjment-2023-300718)
0.00 36
41 Development and validation of a dementia risk score in the U… (10.1136/bmjment-2023-300719)
0.00 45
42 Prescription amphetamines in people with opioid use disorder… (10.1136/bmjment-2023-300728)
0.00 15
43 Patients <i>requesting</i> and <i>receiving</i> euthanasia f… (10.1136/bmjment-2023-300729)
0.00 23
44 Beneficial and harmful effects of tricyclic antidepressants… (10.1136/bmjment-2023-300730)
0.00 18
45 Positive affect training to reduce mental health problems du… (10.1136/bmjment-2023-300737)
0.00 7
46 Qualitative evidence regarding the experience of receiving a… (10.1136/bmjment-2023-300755)
0.00 5
47 Physical injuries as triggers for self-harm: a within-indivi… (10.1136/bmjment-2023-300758)
0.00 5
48 New living evidence resource of human and non-human studies… (10.1136/bmjment-2023-300759)
0.00 27
49 Associations between air pollution and mental health service… (10.1136/bmjment-2023-300762)
0.00 6
50 Adjunctive agents to antipsychotics in schizophrenia: a syst… (10.1136/bmjment-2023-300771)
0.00 27